Liftstream is an executive search recruitment company in the life sciences sector
Aegerion and NPS Pharmaceuticals begin rare disease product launches
Authored by Karl Simpson
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Aegerion Pharma, CHMP positive opinion, commercial opportunities, commercialisation, Dan Rader, Dick Gregg, EMA, europe, Gattex, HoFH, Juxtapid, LOJUXTA, novel therapies, NPS pharma, orphan designation, Orphan drugs, Rare Disease, Revestive, short bowel syndrome, Takeda, USA
Leave a comment